{"id":"https://openalex.org/W2065582045","doi":"https://doi.org/10.1517/13543784.16.4.533","title":"Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for Type 2 diabetes","display_name":"Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for Type 2 diabetes","alternate_titles":[],"publication_year":2007,"publication_date":"2007-03-20","ids":{"openalex":"https://openalex.org/W2065582045","doi":"https://doi.org/10.1517/13543784.16.4.533","mag":"2065582045","pmid":"https://pubmed.ncbi.nlm.nih.gov/17371200"},"language":"en","primary_location":{"id":"doi:10.1517/13543784.16.4.533","doi":"https://doi.org/10.1517/13543784.16.4.533","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.16.4.533","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2065582045"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054335526","display_name":"Carolyn Fiona Deacon","orcid":"https://orcid.org/0000-0003-2611-5642","observed_orcids":["https://orcid.org/0000-0003-2611-5642"]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]}],"countries":["DK"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Carolyn F Deacon","raw_affiliation_strings":["Panum Institute, Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark. deacon@mfi.ku.dk","Panum Institute, Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Panum Institute, Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark. deacon@mfi.ku.dk","institution_ids":["https://openalex.org/I124055696"]},{"raw_affiliation_string":"Panum Institute, Department of Biomedical Sciences, University of Copenhagen, Copenhagen N, Denmark","institution_ids":["https://openalex.org/I124055696"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5054335526"],"corresponding_institution_ids":["https://openalex.org/I124055696"],"apc_list":null,"apc_paid":null,"fwci":0.9114,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.68212928,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"16","issue":"4","first_page":"533","last_page":"545"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":1.0},{"id":"https://openalex.org/keywords/dpp-4-inhibition","display_name":"DPP-4 inhibition","score":0.9269999861717224},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9789999723434448},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9580000042915344},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.7429999709129333},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.8870000243186951},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.972000002861023},{"id":"https://openalex.org/keywords/glycosylated-haemoglobin","display_name":"glycosylated haemoglobin","score":0.8830000162124634},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.902999997138977},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7710000276565552}],"concepts":[{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.9883952736854553},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.7986576557159424},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7470998764038086},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.7416930198669434},{"id":"https://openalex.org/C2778199505","wikidata":"https://www.wikidata.org/wiki/Q2992990","display_name":"Postprandial","level":3,"score":0.7020325660705566},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.6721768379211426},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.666471540927887},{"id":"https://openalex.org/C2910260750","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin Phosphate","level":5,"score":0.6140850782394409},{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.57773756980896},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.550003170967102},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5335783362388611},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4928467273712158},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.43317484855651855},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.426252543926239},{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.4216618239879608},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000243","descriptor_name":"Adenosine Deaminase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D006023","descriptor_name":"Glycoproteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018819","descriptor_name":"Dipeptidyl Peptidase 4","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D058892","descriptor_name":"Adenosine Deaminase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1517/13543784.16.4.533","doi":"https://doi.org/10.1517/13543784.16.4.533","is_oa":false,"landing_page_url":"https://doi.org/10.1517/13543784.16.4.533","pdf_url":null,"source":{"id":"https://openalex.org/S131064935","display_name":"Expert Opinion on Investigational Drugs","issn_l":"1354-3784","issn":["1354-3784","1744-7658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Investigational Drugs","raw_type":"journal-article"},{"id":"pmid:17371200","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17371200","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on investigational drugs","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/92731200-ab49-11dd-b5e9-000ea68e967b","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/92731200-ab49-11dd-b5e9-000ea68e967b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Deacon, C F 2007, 'Dipeptidyl peptidase 4 inhibition with sitagliptin: a new therapy for type 2 diabetes.', Expert Opinion on Investigational Drugs, vol. 16, no. 4, pp. 533-45. https://doi.org/10.1517/13543784.16.4.533","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W135031980","https://openalex.org/W1585447752","https://openalex.org/W1909310469","https://openalex.org/W1967130535","https://openalex.org/W1977009119","https://openalex.org/W1978953702","https://openalex.org/W1986331352","https://openalex.org/W1987507938","https://openalex.org/W1993287695","https://openalex.org/W1994743271","https://openalex.org/W1997024473","https://openalex.org/W2018192866","https://openalex.org/W2020267609","https://openalex.org/W2021624889","https://openalex.org/W2021836468","https://openalex.org/W2028849170","https://openalex.org/W2030861315","https://openalex.org/W2033661046","https://openalex.org/W2036993603","https://openalex.org/W2042845313","https://openalex.org/W2048876290","https://openalex.org/W2049222364","https://openalex.org/W2051462052","https://openalex.org/W2054185381","https://openalex.org/W2056391616","https://openalex.org/W2068183831","https://openalex.org/W2074835704","https://openalex.org/W2081276121","https://openalex.org/W2083473802","https://openalex.org/W2084139518","https://openalex.org/W2085862152","https://openalex.org/W2087707716","https://openalex.org/W2089304685","https://openalex.org/W2095227308","https://openalex.org/W2097643798","https://openalex.org/W2101877785","https://openalex.org/W2104763836","https://openalex.org/W2106558322","https://openalex.org/W2109157463","https://openalex.org/W2113544353","https://openalex.org/W2123355624","https://openalex.org/W2123629330","https://openalex.org/W2127409471","https://openalex.org/W2145140318","https://openalex.org/W2145266416","https://openalex.org/W2145335273","https://openalex.org/W2146232529","https://openalex.org/W2146333376","https://openalex.org/W2148182710","https://openalex.org/W2153449155","https://openalex.org/W2171512247","https://openalex.org/W2326146948","https://openalex.org/W4234825176"],"related_works":["https://openalex.org/W3192932278","https://openalex.org/W2099092932","https://openalex.org/W2109211688","https://openalex.org/W2349050808","https://openalex.org/W2048981028","https://openalex.org/W2136752386","https://openalex.org/W2036167297","https://openalex.org/W2400229282","https://openalex.org/W1976509155","https://openalex.org/W4322759065"],"abstract_inverted_index":{"Sitagliptin":[0],"is":[1,18,31,97,107],"a":[2,54,64,103,114],"once-daily,":[3],"orally":[4],"active,":[5],"competitive":[6],"and":[7,56,83,99,119,134],"fully":[8],"reversible":[9],"inhibitor":[10],"of":[11,24,38,48,69,111,117],"dipeptidyl":[12],"peptidase":[13],"4,":[14],"the":[15,21,25,32,46,112],"enzyme":[16],"that":[17,106,110],"responsible":[19],"for":[20,45,57],"rapid":[22],"degradation":[23],"incretin":[26],"hormone":[27],"glucagon-like":[28],"peptide-1.":[29],"It":[30,96],"first":[33],"in":[34,59,92],"this":[35],"new":[36],"class":[37],"antihyperglycaemic":[39],"agents":[40],"to":[41,88,109],"gain":[42],"regulatory":[43],"approval":[44],"treatment":[47],"Type":[49],"2":[50],"diabetes,":[51],"both":[52,81],"as":[53],"monotherapy":[55],"use":[58],"combination":[60],"with":[61,102,126],"metformin":[62],"or":[63,71],"thiazolidinedione.":[65],"In":[66],"clinical":[67,124],"trials":[68],"<":[70],"=":[72],"1-year":[73],"duration,":[74],"sitagliptin":[75,127],"improves":[76],"glycaemic":[77],"control":[78],"by":[79],"reducing":[80],"fasting":[82],"postprandial":[84],"glucose":[85],"concentrations,":[86],"leading":[87],"clinically":[89],"meaningful":[90],"reductions":[91],"glycosylated":[93],"haemoglobin":[94],"levels.":[95],"safe":[98],"well":[100],"tolerated,":[101],"side-effect":[104],"profile":[105],"similar":[108],"placebo,":[113],"low":[115],"incidence":[116],"hypoglycaemia":[118],"body":[120],"weight":[121],"neutrality.":[122],"Further":[123],"experience":[125],"will":[128],"reveal":[129],"its":[130],"long-term":[131],"durability,":[132],"safety":[133],"efficacy.":[135]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2065582045","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
